ReviewFrontiers in neurology2026
Capillary stalling after traumatic brain injury: an emerging microcirculatory contributor to secondary brain injury.
Review in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Secondary brain injury after traumatic brain injury (TBI) has traditionally been understood and managed through the lens of intracranial pressure, cerebral perfusion pressure, and global cerebral blood flow. Yet a substantial proportion of patients continue to exhibit persistent tissue hypoxia and metabolic crisis even when these macrocirculatory parameters appear adequately controlled. Capillary stalling-the transient or sustained interruption of red blood cell transit within individual or focal capillary networks-may represent an under-recognized microcirculatory disorder that conventional macrovascular monitoring cannot capture. This review synthesizes evidence supporting capillary stalling as a potentially distinct and reversible component of post-traumatic microvascular failure. We examine candidate mechanisms of capillary flow interruption after TBI, including endothelial injury and glycocalyx disruption, leukocyte plugging, pericyte contraction, platelet activation and microthrombosis, red blood cell dysfunction, and edema-associated extravascular compression. These mechanisms can generate marked capillary flow heterogeneity, impair oxygen extraction, and contribute to metabolic crisis, neuroinflammation, and secondary neuronal injury. We further discuss why conventional bedside monitoring-including intracranial pressure, cerebral perfusion pressure, global cerebral blood flow, brain tissue oxygenation, and microdialysis-may fail to detect capillary-level flow abnormalities, and we review established and emerging detection strategies from experimental two-photon microscopy to clinical surrogates. Finally, we evaluate potential microcirculation-targeted therapeutic avenues. Direct evidence of capillary stalling in human TBI remains limited; accordingly, it should currently be viewed as a biologically plausible and testable contributor to secondary brain injury rather than an established dominant driver.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.